In-Depth Examination Of 4 Analyst Recommendations For Ingevity
Portfolio Pulse from Benzinga Insights
Ingevity (NYSE:NGVT) has received mixed analyst ratings over the past three months, with all four analysts rating it as 'Indifferent'. The average 12-month price target is $42.25, a slight decline from previous estimates. Ingevity faces financial challenges, including a negative revenue trend, low net margin, and high debt-to-equity ratio.
October 31, 2024 | 5:05 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Ingevity has received 'Indifferent' ratings from analysts, with a 12-month price target of $42.25. The company faces financial challenges, including a negative revenue trend, low net margin, and high debt-to-equity ratio.
The 'Indifferent' ratings from analysts suggest a neutral outlook, but the financial challenges such as negative revenue growth, low net margin, and high debt-to-equity ratio indicate potential downside risks for Ingevity's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100